retatrutide fda approval status october 2025 This weight-loss drug hasn't been approved by the FDA. Doctors are prescribing it anyway TRIUMPH-4: Retatrutide Beat Every Prediction

Unlike other peptide medications that only target one specific area (GLP-1), tirzepatide has the ability to target two areas at once (GLP-1 & GIP)

Key points: Leverage platform data from similar biologics Eliminate redundant toxicology studies Combine endpoints within the same study Use in vitro and computational models earlier Align with the 3Rs principle (Replacement, Reduction, Refinement) Important step toward more ethical and efficient ocular drug development

2.8% said they used them for 11 months

The demand as well as the use of GLP-1 drugs for the treatment of type 2 diabetes and obesity is increasing

Yes, GLP-1based medications have received FDA approval for weight loss treatment

The high-dose group also lost 28% of body weight after eight months, while the low-dose group lost 24%